• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Collections Ceilings, Collections Realized, and Offset: FY 2011 AGDUFA Financial Report

Back to Table of Contents: FY 2011 AGDUFA Financial Report

Under AGDUFA, if the cumulative collections through FY 2011, including an estimate for FY 2012, exceed the fee revenue amounts specified in the Appropriations Act for that period, FDA will reduce the fee rates for FY 2013 by the cumulative amount that fees exceeded the appropriations during that period. 

Table 4 depicts FY 2011 fee collections realized (the same as total collections in Table 1), collection ceilings specified in the Appropriations Act, and amounts that may be subject to offset in a future fiscal year. 

Table 4
Generic New Animal Drug User Fees Collected, Collections
Ceiling, and Offset Amounts
As of September 30, 2011 

 2009 $5,099,084 $4,831,000 $268,084
 2010 $4,392,209 $5,106,000 ($713,791)
 2011 $4,942,876 $5,397,000 ($454,124)
   TOTAL ($899,831)
Balance to be Offset in a Subsequent Fiscal Year   $0

As discussed earlier on page 4, previous cohort year collections realized in FY 2011 have been updated from last year’s report.  The update reflects net collections for each cohort year through September 30, 2011.  Cohort year fees collected subsequent to September 30, 2011 will be reported in the FY 2012 financial report.

Next Section: Reserves and Balance Available for Allocation – FY 2011 AGDUFA Financial Report